[1] CATTRAN D C,COPPO R,COOK H T,et al.The Oxford classification of IgA nephropathy:rationale,clinicopathological correlations,and classification[J].Kidney Int,2009,76:534-545.
[2] SMITH S W,SCHRIMPF C,PAREKH D J,et al.Kidney pericytes:a novel therapeutic target in interstitial fibrosis[J].Histol Histopathol,2012,27(12):1503-1514.
[3] FARRIS A B,COLVIN R B.Renal interstitial fibrosis:mechanisms and evaluation[J].Curr Opin Nephrol Hypertens,2012,21(3):289-300.
[4] MYLLYMAKI J M,HONKANEN T T,SYRJANEN J T,et al.Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy-348.
[5] ALEXOPOULOS E,SERON D,HARTLEY R B,et a1.The role of interstitial infiltrates in IgA nephropathy:a study with monoclonal antibodies-195.
[6] HAMEL K,DOODES P,CAO Y,et al.Suppression of proteoglycan-induced arthritis by anti-CD20 B cell depletion therapy is mediated by reduction in autoantibodies and CD4+T cell reactivity-5003.
[7] KURTULUS S,HILDEMAN D.Assessment of CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers-79.
[8] STEPHEN R H,KITCHING A,PETER G T.Thl and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis[J].Kidney Int,1999,55:1198-1216.
[9] STEINMETZ O M,VELDEN J,KNEISSLER U,et al.Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis-457.
[10] COHEN C D,CALVARESI N,ARMELLONI S,et al.CD20-positive infiltrates in human membranous glomerulonephritis-333.
[11] MENGEL M,GWINNER W,SCHWARZ A,et al.Infiltrates in protocol biopsies from renal allografts-365.
[12] HIPPEN B E,DeMATTOS A,COOK W J,et al.Association of CD20+infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts-2252.
[13] 王惠,许旌,张洪.2型糖尿病患者外周血T淋巴细胞亚群和NK细胞的变化及其临床意义[J].现代医学,2010,38(2):137-140. |